Sponsor pipeline

Staidson (Beijing) Biopharmaceuticals Co., Ltd clinical trial pipeline

Get alerts when Staidson (Beijing) Biopharmaceuticals Co., Ltd's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

First postedNew trial filingPhaseStatus
2026-09-22 NCT07833943 A Study to Evaluate the Safety and Efficacy of Multiple Dose of STSP-0902 in Patients… Phase 2 Not Yet Recruiting

Active trials by phase

Phase 1
1
Phase 2
2
Phase 3
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT07168161 BDB-001 Phase III Trial in ANCA-Associated Vasculitis ANCA Associated Vasculitis (AAV) Recruiting 2026-08-13
NCT07208591 To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acute… Acute Respiratory Distress Syndrome (ARDS) Recruiting 2026-01-02
Phase 2
NCT06975748 A Phase II Study of STSP-0902 Ophthalmic Solution in Patients With Neurotrophic Keratitis Neurotrophic Keratitis Recruiting 2026-04-07
NCT07833943 A Study to Evaluate the Safety and Efficacy of Multiple Dose of STSP-0902 in Patients… Oligozoospermia and/or Asthenozoospermia Not Yet Recruiting 2026-09-22
Phase 1
NCT06948799 A Study to Evaluate the Safety and Tolerability of Single and Multiple Dose of STSP-0902… Oligozoospermia Recruiting 2026-05-22
Get alerts when Staidson (Beijing) Biopharmaceuticals Co., Ltd's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free